Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney(University of Washington), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert H. Carnahan(Vanderbilt University Medical Center), Rachel E. Sutton(Vanderbilt University Medical Center), Rachel Eguia(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pavlo Gilchuk(AstraZeneca (Japan)), Zhuoming Liu(Washington University in St. Louis), James E. Crowe(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Elad Binshtein, Paul W. Rothlauf(Harvard University), Naveenchandra Suryadevara(Vanderbilt University), John Huddleston(Howard Hughes Medical Institute), Katharine H. D. Crawford(University of Washington), Sarah K. Hilton(Biogen (United States)), Seth J. Zost(Vanderbilt University Medical Center), Sean P. J. Whelan(University of Pittsburgh Medical Center), Andrea N. Loes(Howard Hughes Medical Institute), Adam S. Dingens(Fred Hutch Cancer Center), Tyler N. Starr(University of Utah)
Cited by 1,154
Related Papers
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
|Science Immunology|2020|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851